Michael Okonkwo

Michael Okonkwo

IPO & Growth Analyst

Michael Okonkwo is an IPO and growth equity analyst at StockTi. He holds an MBA from Wharton and previously worked in venture capital, giving him a unique perspective on pre-IPO valuations and public market debuts. Michael covers new listings, SPAC transactions, and high-growth companies across all sectors. His analysis focuses on identifying inflection points in emerging companies transitioning from private to public markets.

IPO, Growth Stocks 180 articles

Articles by Michael Okonkwo

SpaceX IPO on Horizon: Assessing Investment Risks and Rewards
IPO

SpaceX IPO on Horizon: Assessing Investment Risks and Rewards

SpaceX's June IPO is imminent, but a $5B net loss and lofty valuation temper enthusiasm. Analysts weigh growth against risks.

MNTN RTX MRCY POET
AMSS Shares Surge on Good Twin Sales and $6.99M Convertible Deal
IPO

AMSS Shares Surge on Good Twin Sales and $6.99M Convertible Deal

AMASS Brands shares surged following strong sales of its Good Twin organic non-alcoholic wine and a $6.99 million convertible funding deal. The stock remains volatile in its first week on Nasdaq.

STZ SAM CELH
Redwire Surges on SpaceX IPO Hype, But Losses Loom
IPO

Redwire Surges on SpaceX IPO Hype, But Losses Loom

Redwire shares surged 26% on Tuesday, riding the wave of SpaceX IPO anticipation and Starship test success. Despite strong revenue growth and a record backlog, ongoing losses and potential share dilution temper the rally.

RDW RKLB ASTS
Safepoint IPO Roadshow Targets $1.16 Billion Valuation Amid Strong Earnings Growth
IPO

Safepoint IPO Roadshow Targets $1.16 Billion Valuation Amid Strong Earnings Growth

Safepoint, a Florida-based specialty insurer, has begun its IPO roadshow targeting a $1.16 billion valuation, seeking to raise up to $283.3 million.

SPY GLD SLV USO UNG XLK XLF XLE XLV FXI MCHI
Firefly Aerospace Stock Swings on Lunar Contract and Share Offering
IPO

Firefly Aerospace Stock Swings on Lunar Contract and Share Offering

Firefly Aerospace shares surged 18.8% after a $75M NASA contract, then fell 4.9% after-hours on a 12M share offering. Space stocks rally on SpaceX IPO buzz.

RKLB ASTS RDW
Honeywell's Quantum Unit Sets Sights on $12.7B Valuation in IPO
IPO

Honeywell's Quantum Unit Sets Sights on $12.7B Valuation in IPO

Quantinuum aims for a $12.7B valuation in its U.S. IPO, seeking up to $1.05B. Honeywell will retain about 49% voting rights.

HON IONQ RGTI QBTS IBM
AST SpaceMobile Stock Surges 26.5% as SpaceX IPO Buzz Lifts Space Sector
IPO

AST SpaceMobile Stock Surges 26.5% as SpaceX IPO Buzz Lifts Space Sector

AST SpaceMobile shares surged 26.5% this week, closing at $105.86, as space stocks rallied on SpaceX IPO speculation. The company plans a mid-June launch for three BlueBird satellites.

ASTS
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
IPO

Medline's $2.7B Secondary Offering Tests Post-IPO Demand

Medline Inc. shareholders sold 72.55 million Class A shares at $37 each in an upsized secondary offering, with the stock closing at $37.01 on Friday. The deal closes May 28.

MCK CAH
Fervo Energy Shares Dip 10% But Stay 42% Above IPO Price Ahead of Key Project Milestone
IPO

Fervo Energy Shares Dip 10% But Stay 42% Above IPO Price Ahead of Key Project Milestone

Fervo Energy shares dropped 9.76% to $38.35 on Friday, but still trade 42% above the IPO price. The company's valuation now near $12.4 billion hinges on its Cape Station geothermal project.

Tema Space ETF Surpasses $1 Billion on SpaceX IPO Buzz
IPO

Tema Space ETF Surpasses $1 Billion on SpaceX IPO Buzz

Tema Space Innovators ETF (NASA) crossed $1 billion in assets after 37 trading days, fueled by SpaceX's IPO filing and Starship test. The fund closed Friday at $38.76, up 6.13%.

RKLB SPCE
Firefly Aerospace Surges 15% on SpaceX IPO Hype, Weekly Gain Hits 22%
IPO

Firefly Aerospace Surges 15% on SpaceX IPO Hype, Weekly Gain Hits 22%

Firefly Aerospace shares surged 15.5% to $49.50 Friday, closing above its August IPO price as SpaceX IPO news reignited interest in space stocks, capping a 22% weekly gain.

FLY RKLB ASTS SPCE
Medline's $2.7B Secondary Offering Tests Post-IPO Demand
IPO

Medline's $2.7B Secondary Offering Tests Post-IPO Demand

Medline's $2.68 billion secondary offering, upsized from 60 million shares, prices at $37 each, with the stock holding near that level.

MDT MCK CAH